|
Low Float Biopharma Profile (Nasdaq: ENTO) Rises To My Watchlist's #1 Spot
March 3rd Dear Reader,
Reaching the top of my watchlist right now is Entero Therapeutics, Inc. (Nasdaq: ENTO).
Entero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted, non-systemic therapies for gastrointestinal (GI) diseases.
ENTO is developing a therapeutic pipeline rooted in a triad of exclusive technological breakthroughs:
Latiglutenase is a potentially first-in-class oral biotherapeutic designed to aid gluten digestion and reduce symptoms of celiac disease, currently in Phase 3-ready status.
Capeserod, a selective 5-HT4 receptor partial agonist, is being developed for multiple GI indications, including gastroparesis.
Adrulipase is a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in patients with exocrine pancreatic insufficiency, particularly those with cystic fibrosis and chronic pancreatitis.
The company is also developing niclosamide-based therapies for ulcerative proctitis and immune checkpoint inhibitor-associated colitis.
Read more about the company here. -----
Entero Therapeutics, Inc. (Nasdaq: ENTO) is a low float breakout idea...
Right now, Yahoo Finance is reporting ENTO have approximately 4.69Mn shares in its float.
What does that mean? It means the volatility potential is elevated from there being so few shares available.
It could also be part of the reason why ENTO was able to climb 92% from a December 5th, 2024 open of $.48 to a December 9th high of $.926.
Now, there is no certainty another short term move like that will happen again, but it's key to take note that this Nasdaq profile's float size is fairly low. -----
Coverage is officially initiated on Entero Therapeutics, Inc. (Nasdaq: ENTO).
When updates are available, I'll be in touch quickly. Talk again soon.
Sincerely, FierceAnalyst | Jaks Swift Editorial Writer
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
FierceInvestor.com (“FierceInvestor” or “FI”) is owned by SWN Media LLC, a single member limited liability company. Data is provided from third-party sources and FierceInvestor is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile FI brings to your attention. Any emojis used do not have a specific defined meaning and may be used inconsistently. We do not provide personalized in.vest.ment advice, are not in.vest.ment advisors, and any profiles we mention are not suitable for all in.vest.ors.
SWN Media LLC has not been compensated for the March 2nd and 3rd, 2025's profile on (ENTO:US). Neither SWN Media LLC or its member own shares of (ENTO:US).
Please see important disclosure information here: https://www.fierceanalyst.net/disclosure/ | 
No comments:
Post a Comment